会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 76. 发明申请
    • Modulators of Preripheral 5-Ht Receptors
    • Preripheral 5-Ht受体的调节剂
    • US20070254874A1
    • 2007-11-01
    • US10583829
    • 2004-12-23
    • Jo KlavenessFinn LevyBjarne Brudeli
    • Jo KlavenessFinn LevyBjarne Brudeli
    • A61K31/445A61K31/535A61P1/00C07D211/06C07D265/04C07D401/00
    • C07D401/12A61K31/343A61K31/404A61K31/415A61K31/4184A61K31/428A61K31/445C07D209/14C07D211/22C07D211/26C07D211/58C07D405/12
    • Novel modulators of 5-HT4 receptors have been developed which have a selectivity for peripheral receptors rather than those of the central nervous systems. Theses include novel derivatives of known modulators as well as entirely novel entities. Surprisingly, the derivatised compounds of the known modulators maintain a high binding affinity to 5-HT4 receptors, despite the presence of an acidic moiety at the end of an optional chain. The entirely novel entities also exhibit good binding affinity to 5-HT4 receptors. All of the compounds of the invention have a common motif which includes a basic nitrogen moiety and an acidic moiety. The compounds of the invention, due at least in part to their high ionisation potential at physiological pH, have the unique properties of selectively for peripheral 5HT4 receptors over those of the CNS, good binding affinity, and selectively of 5HT4 receptors over other serotonin receptors.
    • 已经开发了具有对外周受体而不是中枢神经系统的选择性的5-HT 4受体的新型调节剂。 论文包括已知调制剂的新型衍生物以及完全新颖的实体。 令人惊奇的是,尽管已知调节剂的衍生化合物在任选链的末端存在酸性部分,但仍保持与5-HT 4受体的高结合亲和力。 完全新颖的实体也表现出对5-HT4受体的良好的结合亲和力。 本发明的所有化合物都具有共同的基序,其包括碱性氮部分和酸性部分。 本发明的化合物至少部分地由于其在生理pH下的高电离电位具有对于周围5HT4受体的选择性优于CNS的那些的独特性质,良好的结合亲和力以及5HT4受体的选择性超过其他5-羟色胺受体。